THE SHARE: Change: +0.01 SEK (+10.19%) / Price: 0.12 SEK / Apr 17, 2026, 6:00 pm (CEST)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
    • Corporate Governance
    • Career
  • Technology
    • Physiological Targeting
    • Functional Nanoparticles
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Financial Calendar
    • Equity research
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Spago Nanomedical in media
    • Press Releases
    • Subscribe
    • Presentations
    • Events
    • Image Bank
  • Contact
    • Contact us

  • 21 Dec, 2016
    Redeye intervju med VD för Spago Nanomedical
  • 14 Dec, 2016
    Change of owner structure in Spago Nanomedical
  • 14 Dec, 2016
    Ägarförändring i Spago Nanomedical
  • 7 Dec, 2016
    Spago Nanomedical appoints product candidate in the SpagoPix-project
  • 7 Dec, 2016
    Spago Nanomedical utser produktkandidat i SpagoPix-projektet
  • 6 Dec, 2016
    Swedish nanotechnology a new weapon in the fight against cancer
  • 6 Dec, 2016
    Svensk nanoteknik ett nytt vapen i kampen mot cancer
  • 17 Nov, 2016
    Production of SpagoPix ongoing
  • 17 Nov, 2016
    Produktion av SpagoPix-material pågår
  • 17 Nov, 2016
    Film från presentation vid Stora Aktiedagen 2016-11-14
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 36
  • Previous
  • Next
Back

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2026 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications